[Circulating tissue antigens in multiple sclerosis and hepatocerebral dystrophy]. 1988

V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ

Using complement fixation test (CFT) in cold, the authors measured the circulating tissue antigens of the brain and liver in 50 subjects (22 patients with hepatocerebral dystrophy, 18 with multiple sclerosis and 10 healthy subjects). The total circulating levels of liver and brain antigens were found to be dependent on the activity and progression of the pathological process in these organs. The CFT may be recommended as an additional test for diagnosing the destructive process in the brain and liver of patients with hepatocerebral dystrophy and multiple sclerosis and for assessing the efficacy of the conducted treatment.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
January 1985, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
July 1986, Meditsinskaia sestra,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
October 1988, Akusherstvo i ginekologiia,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
December 1984, Pediatriia,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
January 1973, Neurologia i neurochirurgia polska,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
January 1983, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
May 1965, Sovetskaia meditsina,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
January 1981, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
October 1976, Journal of neurology,
V A Makarova, and Iu F Geskin, and T A Shirokova, and Iu M Zubzhitskiĭ
April 1974, Lancet (London, England),
Copied contents to your clipboard!